Webinar | April 27, 2021

Considerations To Improve Patient Outcomes In Early Drug Development

Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not just a matter of courtesy; a comprehensive examination of the roles played by all participants has the potential to produce faster and more concrete results, leading to improved patient outcomes.

Topics in this presentation include:

  • Developing a framework for handling multiple endpoints for the drug’s go-to-market label
  • Determining the potential of adaptive design for optimizing the trial and evaluating the applicability of various adaptive design approaches
  • Key interactions and questions to ask when seeking regulatory input of pivotal study designs

Featured Speakers:

Abie Ekangaki, Ph.D. Vice President, Statistical Consulting, Premier Research

Rupa Doshi, Executive Director, Program Strategy, Premier Research

Naomi Kautz, Senior Director, Regulatory Affairs, RPI, A Division of Premier Research


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader